SignalPET announces the expansion of business to the Asian Market
The official expansion of the company into Asia and the opening of a new research and development (R&D) centre in Israel are both announced today by SignalPET, a leading provider of veterinary radiology interpretation at the point of care powered by artificial intelligence (AI) and machine learning technology.
Asia is the next logical place to provide the technology because the company controls the market in North America, Europe, and Australia for point-of-care radiograph interpretation systems. The business will soon extend its services to South Korea and Hong Kong in addition to Singapore, bringing its cutting-edge technology to more clinics around the world.
With SAGE Healthcare Pte Ltd, a powerful partner with a solid reputation and complete access to all clinics in the region, the business has inked an exclusive deal. The company's entry into Asia is an important turning point in its development and is evidence of how well and widely used its technology is.
“We are thrilled to be partnering with SignalPET. SignalPET’s unique technology sets a new standard for radiograph interpretation. It truly enables clinicians to pick our subtle radiographic changes, move faster through patients and save time, ensuring the best possible assessment for the patient at the point of care,” says Dr. Bryan Tan, Veterinarian and Business Manager at SAGE Healthcare.”
SignalPET is also announcing the opening of a new research and development (R&D) centre in Israel in addition to the expansion to Asia. The R&D centre will concentrate on cutting-edge technology for the company's goods, boosting clinics all over the world's access to monitoring and AI capabilities.
“Israel has a strong tradition of technological innovation, and we are excited to tap into talent and expertise to improve our product further and meet the demand and expectations of our customers.” Said Rotem Lambez, Vice President of Products. “The new R&D center will allow us to stay at the forefront of the industry and continue to provide the best quality AI in the market today.”
SignalPET is announcing not just the expansion to Asia but also the opening of a new research and development (R&D) facility in Israel. The R&D centre will concentrate on cutting-edge technology for the business's goods, significantly advancing the AI capabilities and clinics' monitoring experiences across the globe.